News

AVS Pulse PIVL

Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy. 

Surgeons Operating On Patient

The syringes included in several convenience kits commonly used by interventional cardiologists and interventional radiologists should not be used. If treatment is necessary and no other devices are available, it should be done with “extreme caution and vigilance.” 

I-MED Radiology Network

America’s largest radiology group has purportedly considered making a bid to buy its Australian counterpart, which tallied over $176 million in adjusted earnings last year. 

idea light bulb innovation

CHAMPIONSGATE, Fla. — Kaihan Krippendorff, MBA, spoke on April 12 during the opening keynote of the Radiology Business Management Association’s annual meeting. 

RBMA Radiology Business Management Association Paradigm Peter Moffatt

CHAMPIONSGATE, Fla. — Moffatt, currently president of radiology AI and coding firm Reasint, is the 2026 winner of the prestigious Calhoun Award. 

brain stethoscope alzheimer's dementia

Radiopharma firm Telix hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer. 

Long Island Jewish Medical Center LIJ interventional suite IR

The 1,100-square-foot space is located at Long Island Jewish Medical Center, a 583-bed acute care facility that treats 80,000 patients per year.

kids playground

The four best states for pediatric healthcare are bunched together geographically. The four worst are nowhere near each other.

Primary Care

Consumer affinity for AI in healthcare has plummeted over the past two years, a new survey report shows. 

That equates to eliminating 6.5 million prior authorization barriers. The results come from a survey of major health plans conducted by AHIP and the Blue Cross Blue Shield Association.

Prem Soman, MD, director of the Cardiac Amyloidosis Center and nuclear cardiology, and associate chief of cardiology at the University of Pittsburgh Medical Center Heart and Vascular Institute presented the late-breaking results from the long-term survival benefits and disease stabilization with the drug acoramidis in patients with transthyretin amyloid cardiomyopathy at ACC 2026.

Patient outcomes clearly show acoramidis reduces both all-cause mortality and cardiovascular hospitalizations, but the study also reinforced the importance of early diagnosis and prompt medical therapy. 
 

Thumbnail

New survey responses delve into how management shakeups at the divisional level affect morale and physician burnout.

Around the web

Stryker, one of the world’s largest medtech companies, has agreed to acquire a rising name in the field of intravascular lithotripsy.